About Cellular Highways
Cellular Highways is a company based in Melbourn (United Kingdom) founded in 2016 by Salman Samson Rogers was acquired by Stem Cell Technologies in June 2025. The company has 9 employees as of March 31, 2022. Cellular Highways operates in a competitive market with competitors including NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
- Headquarter Melbourn, United Kingdom
- Employees 9 as on 31 Mar, 2022
- Founders Salman Samson Rogers
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cellular Highways Limited
- Date of Incorporation 16 Jan, 2018
- Jurisdiction MELBOURN, UNITED KINGDOM
-
Annual Revenue
$104.61 K (USD)38as on Mar 31, 2021
-
Net Profit
-$1.97 M (USD)-41as on Mar 31, 2021
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
9
as on Mar 31, 2022
-
Acquired by
Stem Cell Technologies
(Jun 02, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cellular Highways
Detailed funding history for Cellular Highways
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cellular Highways
Cellular Highways has secured backing from 1 investor. Prominent investors backing the company include Stem Cell Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of cell culture media and ancillary reagents for life science research
|
Locked | Locked | Locked |
Investor details for Cellular Highways
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellular Highways
Investment portfolio details for Cellular Highways
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellular Highways
Detailed financials for Cellular Highways
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellular Highways Comparisons
Peer comparison for Cellular Highways
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellular Highways
Cellular Highways operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops flow cytometry and cell sorting technology
|
|
| Locked | Locked | Locked |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| Locked | Locked | Locked |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
|
| Locked | Locked | Locked |
Developer of a technology to isolate and recover single cells for molecular analysis
|
|
| Locked | Locked | Locked |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| Locked | Locked | Locked |
Cell and molecular-based diagnostics for cancer management are developed.
|
Detailed competitors of Cellular Highways
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellular Highways
Complete news archive for Cellular Highways
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellular Highways
Cellular Highways was founded in 2016.
Cellular Highways is headquartered in Melbourn, United Kingdom. It is registered at Melbourn, Cambridgeshire, United Kingdom.
Salman Samson Rogers is the current CEO of Cellular Highways. They have also founded this company.
As of Mar 31, 2022, the latest employee count at Cellular Highways is 9.
Annual revenue of Cellular Highways is $104.61K as on Mar 31, 2021.
Cellular Highways was founded in 2016 in Melbourn, United Kingdom, within the biotechnology sector. Automated high-throughput cell sorting instruments are developed using microfluidic technology. These devices are applied in research, diagnostic, and therapeutic contexts to facilitate cell separation and analysis. Operations focus on instrument innovation for laboratory and clinical use, with the company led by co-founder and CEO Salman Samson Rogers.
Cellular Highways's top competitors include NanoCellect Biomedical, ThinkCyte and Silicon Biosystems.
Cellular Highways has 1 investor. Key investors include Stem Cell Technologies.